ABBV vs WFC: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-19.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Wells Fargo & Company · Financial Services
$86.12
+20.4% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
WFC has more upside to fair value
(+20.4%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
WFC |
| Current Price |
$261.70 |
$86.12 |
| Fair Value Estimate |
$259.04 |
$103.68 |
| Upside to Fair Value |
-1.0%
|
+20.4%
|
| Market Cap |
$462.4B |
$260.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
15.6x
|
| Price / Sales |
7.2x
|
2.0x
|
| Price / FCF |
23.6x
|
13.7x
|
| Revenue Growth YoY |
+10.2%
|
+11.3%
|
| Gross Margin |
71.5%
|
64.5%
|
| Operating Margin |
29.3%
|
21.2%
|
| Return on Equity |
-136.5%
|
12.6%
|
| Dividend Yield |
2.61% |
2.15% |
| FCF Yield |
4.25%
|
7.3%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while…
Accumulation Zones
| Metric |
ABBV |
WFC |
| Zone Low |
$194.28 |
$77.76 |
| Zone High |
$220.18 |
$88.13 |
| In Buy Zone? |
No
|
Yes
|